Natalie Galanina

Real-world data from a molecular tumor board demonstrates improved outcomes with a precision N-of-One strategy

Shumei Kato, Ki Hwan Kim, Hyo Jeong Lim et al. · Nature Communications · 2020 · 276 citations · Full text

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL

Sabah Kadri, Jimmy Lee, Carrie Fitzpatrick et al. · Blood Advances · 2017 · 131 citations · Full text

Successful Treatment of HIV-Associated Kaposi Sarcoma with Immune Checkpoint Blockade

Natalie Galanina, Aaron M. Goodman, Philip R Cohen et al. · Cancer Immunology Research · 2018 · 110 citations · Full text

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL

Shruti Sharma, Natalie Galanina, Ailin Guo et al. · Oncotarget · 2016 · 88 citations · Full text

Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma

Jimmy Lee, Liang Leo Zhang, Wenjun Wu et al. · Blood Advances · 2018 · 60 citations · Full text